Document is current
Any future updates will be listed below
-
Authors
Mancini, Francesca Romana
Frénoy, Pauline
Cano-Sancho, German
Marques, Chloé
Ren, Xuan
Perrin, Claire
Perduca, Vittorio
Marchand, Philippe
Le Bizec, Bruno
Antignac, Jean-Philippe
Severi, Gianluca
-
Funding
Funding for this research was provided by:
Fondation de France (00110200.)
Mutuelle Générale de l’Education Nationale
Gustave Roussy Institute
Ligue Contre le Cancer
Agence Nationale de la Recherche (ANR-10-COHO-0006)
Ministère de l'Enseignement supérieur et de la Recherche
- License Information
-
More Information
Article History
Received: 15 April 2026
Accepted: 10 September 2026
First Online: 28 September 2026
Declarations
Ethics approval and consent to participate: The E3N-Generations study was approved by the French National Commission for Data Protection and Privacy (ClinicalTrials.gov identifier: NCT03285230). The E3N Generations blood collection study was approved by the Bicêtre ethics committee (CPP-IDF-VII, IRB # IORG0001140).
Consent for publication: All participants included in the E3N-Generations study gave written informed consent, and informed consent was obtained for novel biomarkers testing.
Competing interests: The authors declare no competing interests.
